HALO logo
halo search icon
RO
Roche Holding Ltd

RO · Roche Holding Ltd

375.60

CHF
-4.00 (-1.054%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Fr304.38B

PE

20.70

EV/EBITDA

12.8

DIV Yield

2.9%

Payout Ratio

61%

MQV Rating

3Neutral

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Capital Efficiency
  • Near 52 Week High
  • Near Resistance
  • Near Resistance (Realtime)
  • Short Term Trend - Long

Key Fundamentals

EPS 3 yr Growth

4.20%

EBITDA Margin

36.80%

Operating Cashflow

SFr17,830m

Free Cash Flow Return

28.20%

ROIC

20.40%

Interest Coverage

19.10

Quick Ratio

1.10

Performance

52 weeks range

Low 264.6 - 383

Trade Value (12mth)

US$2,928,986.00

1 week

4.92%

1 month

5.44%

YTD

13.93%

1 year

38.34%

All time high

439.20

Additional Data

Shares Outstanding (Fully Diluted)

807m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

12-Mar-26

Next Dividend Pay Date

16-Mar-26

Reporting Currency

CHF

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Neutral

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Hoffmann FamilyIndividual
Melchior OeriIndividual
Maja OeriIndividual
Severin SchwanIndividual
Alan HippeIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Roche Holding Ltd (RO:SWX)?
Halo FAQ
The current share price of Roche Holding Ltd (RO:SWX) is CHFCHF375.60.
2
What is the 52-week high share price for Roche Holding Ltd (RO:SWX)?
Halo FAQ
The 52-week high share price for Roche Holding Ltd (RO:SWX) is CHFCHF383.00.
3
What is the 52-week low share price for Roche Holding Ltd (RO:SWX)?
Halo FAQ
The 52-week low share price for Roche Holding Ltd (RO:SWX) is CHFCHF264.60.
4
What is the dividend yield for Roche Holding Ltd (RO:SWX)?
Halo FAQ
The current TTM dividend payout for Roche Holding Ltd (RO:SWX) is 2.90.
5
What was Roche Holding Ltd (RO:SWX) last dividend payment?
Halo FAQ
The last dividend payment of Roche Holding Ltd (RO:SWX) is CHFCHF9.80.
6
What is the franking level for Roche Holding Ltd (RO:SWX)?
Halo FAQ
Roche Holding Ltd (RO:SWX) has a franking level of 0.00%.
7
In which sector is Roche Holding Ltd (RO:SWX) classified?
Halo FAQ
Roche Holding Ltd (RO:SWX) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Roche Holding Ltd (RO:SWX)?
Halo FAQ
The current P/E ratio for Roche Holding Ltd (RO:SWX) is 20.70.